Temporal association of prostate cancer incidence with World Trade Center rescue/recovery work
- PMID: 34507966
- PMCID: PMC8458078
- DOI: 10.1136/oemed-2021-107405
Temporal association of prostate cancer incidence with World Trade Center rescue/recovery work
Abstract
Background: The World Trade Center (WTC) attacks on 11 September 2001 created a hazardous environment with known and suspected carcinogens. Previous studies have identified an increased risk of prostate cancer in responder cohorts compared with the general male population.
Objectives: To estimate the length of time to prostate cancer among WTC rescue/recovery workers by determining specific time periods during which the risk was significantly elevated.
Methods: Person-time accruals began 6 months after enrolment into a WTC cohort and ended at death or 12/31/2015. Cancer data were obtained through linkages with 13 state cancer registries. New York State was the comparison population. We used Poisson regression to estimate hazard ratios and 95% CIs; change points in rate ratios were estimated using profile likelihood.
Results: The analytic cohort included 54 394 male rescue/recovery workers. We observed 1120 incident prostate cancer cases. During 2002-2006, no association with WTC exposure was detected. Beginning in 2007, a 24% increased risk (HR: 1.24, 95% CI 1.16 to 1.32) was observed among WTC rescue/recovery workers when compared with New York State. Comparing those who arrived earliest at the disaster site on the morning of 11 September 2001 or any time on 12 September 2001 to those who first arrived later, we observed a positive, monotonic, dose-response association in the early (2002-2006) and late (2007-2015) periods.
Conclusions: Risk of prostate cancer was significantly elevated beginning in 2007 in the WTC combined rescue/recovery cohort. While unique exposures at the disaster site might have contributed to the observed effect, screening practices including routine prostate specific antigen screening cannot be discounted.
Keywords: environmental exposure; exposures or occupational groups; longitudinal studies; materials; medical oncology; risk assessment.
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Comment in
-
Urological Oncology: Prostate Cancer.J Urol. 2022 Jan;207(1):229-231. doi: 10.1097/JU.0000000000002285. Epub 2021 Oct 18. J Urol. 2022. PMID: 34662205 No abstract available.
References
-
- Breslow NE, Day NE. Statistical methods in cancer research. Volume I - The analysis of case-control studies. IARC Sci Publ 1980;32:5–338. - PubMed
Publication types
MeSH terms
Grants and funding
- HHSN261201800032C/CA/NCI NIH HHS/United States
- HHSN261201800009C/CA/NCI NIH HHS/United States
- U01 OH011931/OH/NIOSH CDC HHS/United States
- HHSN261201800015I/CA/NCI NIH HHS/United States
- U01OH011315/ACL/ACL HHS/United States
- U01 OH011932/OH/NIOSH CDC HHS/United States
- U50 TS272750/TS/ATSDR CDC HHS/United States
- HHSN261201800032I/CA/NCI NIH HHS/United States
- U50 OH009739/OH/NIOSH CDC HHS/United States
- P30 CA013330/CA/NCI NIH HHS/United States
- U01 OH011681/OH/NIOSH CDC HHS/United States
- NU58DP006344/DP/NCCDPHP CDC HHS/United States
- U01 OH011480/OH/NIOSH CDC HHS/United States
- U50OH009739/ACL/ACL HHS/United States
- HHSN261201800015C/CA/NCI NIH HHS/United States
- HHSN261201800009I/CA/NCI NIH HHS/United States
- U01 OH011315/OH/NIOSH CDC HHS/United States
LinkOut - more resources
Full Text Sources
Medical